Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash Flows from Operating Activities:
Net income	$ 11,451	$ 9,230
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,507	2,665
Provision for bad debts	(300)	1,540
Stock issued for costs and expenses		76
Compensatory element of stock issuances		53
(Increase) decrease in operating assets, net:
Accounts, medical receivable(s) and management fee	(3,674)	(4,310)
Notes receivable	17	118
Costs and estimated earnings in excess of billings on uncompleted contracts	403	79
Inventories	(43)	158
Prepaid expenses and other current assets	9	89
Other assets	(143)	18
Increase (decrease) in operating liabilities, net:
Accounts payable	(437)	(178)
Other current liabilities	576	(501)
Customer advances	(427)	(259)
Billings in excess of costs and estimated earnings on uncompleted contracts	112
Other liabilities	249	(230)
Due to related medical practices		(2)
Net cash provided by operating activities	10,300	8,546
Cash Flows from Investing Activities:
Purchases of property and equipment	(534)	(125)
Cost of patents	(65)	(108)
Net cash used in investing activities	(599)	(233)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(1,871)	(2,166)
Distributions to noncontrolling interests	(4,138)	(3,306)
Buyout of noncontrolling interests		(4,971)
Repayment of notes receivable from employee stockholders	6	6
Net cash used in financing activities	(6,003)	(10,437)
Net Increase in Cash and Cash Equivalents	3,698	(2,124)
Cash and Cash Equivalents - Beginning of Period	9,449	9,952
Cash and Cash Equivalents - End of Period	$ 13,147	$ 7,828